Logo

Elan Pharma Licenses Ariadne's Software

Nov 30, 2007
NEW YORK (GenomeWeb News) – Elan Pharmaceuticals has licensed Ariadne Genomics’ Pathway Studio software to support its therapeutics research for neurological and autoimmune diseases, Ariadne said Thursday.
 
The Pathway Studio includes the ResNet database of functional relationships, which is used to interpret microarray data and for researching signaling networks, and MedScan, which is a tool that extracts pathway related information from research literature.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.